| 000 | 01459 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517130326.0 | ||
| 264 | 0 | _c20171212 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1752-8062 | ||
| 024 | 7 |
_a10.1111/cts.12433 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNagy, C F | |
| 245 | 0 | 0 |
_aAnimal-to-Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule. _h[electronic resource] |
| 260 |
_bClinical and translational science _c01 2017 |
||
| 300 |
_a12-19 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnthrax _xdrug therapy |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 |
_aAntitoxins _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMacaca fascicularis |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aRespiratory Tract Infections _xdrug therapy |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTranslational Research, Biomedical |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 700 | 1 | _aMondick, J | |
| 700 | 1 | _aSerbina, N | |
| 700 | 1 | _aCasey, L S | |
| 700 | 1 | _aCarpenter, S E | |
| 700 | 1 | _aFrench, J | |
| 700 | 1 | _aGuttendorf, R | |
| 773 | 0 |
_tClinical and translational science _gvol. 10 _gno. 1 _gp. 12-19 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/cts.12433 _zAvailable from publisher's website |
| 999 |
_c26673486 _d26673486 |
||